<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02544230</url>
  </required_header>
  <id_info>
    <org_study_id>GTX.01</org_study_id>
    <nct_id>NCT02544230</nct_id>
  </id_info>
  <brief_title>Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia</brief_title>
  <official_title>Efficacy of Granulocyte Transfusions for the Treatment of Severe Infections in Hematological Patients With Febrile Neutropenia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators retrospectively evaluated the efficacy of granulocyte transfusions as
      adjunctive treatment for severe infections in neutropenic fever unresponsive to antimicrobial
      therapy in hematological patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Infection-related mortality</measure>
    <time_frame>within 30 days after the last granulocyte transfusion</time_frame>
    <description>deaths due to infection occurred within 30 days after the last granulocyte transfusion</description>
  </primary_outcome>
  <enrollment type="Actual">101</enrollment>
  <condition>Neutropenia</condition>
  <condition>Fever</condition>
  <condition>Bacterial Infection</condition>
  <condition>Fungal Infection</condition>
  <condition>Fever of Unknown Origin</condition>
  <condition>Hematological Neoplasms</condition>
  <condition>Sepsis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with malignant emopatia who received granulocyte transfusions as adjunctive
        therapy in the treatment of severe infection, unresponsive to appropriate antimicrobial
        therapy, which was incurred during neutropenia.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  fever;

          -  presence of absolute neutrophil count &lt;0.5 x 10^9/L

          -  evidence of bacterial or fungal infections (including clinical signs of infection,
             positive cultures or biopsy, and radiological evidences)

          -  unresponsiveness to appropriate antimicrobial therapy for at least 48 hours

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Catholic University of Sacred Heart</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Estcourt LJ, Stanworth S, Doree C, Blanco P, Hopewell S, Trivella M, Massey E. Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2015 Jun 29;(6):CD005341. doi: 10.1002/14651858.CD005341.pub3. Review.</citation>
    <PMID>26118415</PMID>
  </reference>
  <reference>
    <citation>Stanworth SJ, Massey E, Hyde C, Brunskill S, Lucas G, Navarrete C, Marks DI. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005339. Review. Update in: Cochrane Database Syst Rev. 2016;4:CD005339.</citation>
    <PMID>16034970</PMID>
  </reference>
  <reference>
    <citation>Strauss RG. Role of granulocyte/neutrophil transfusions for haematology/oncology patients in the modern era. Br J Haematol. 2012 Aug;158(3):299-306. doi: 10.1111/j.1365-2141.2012.09190.x. Epub 2012 Jun 19. Review.</citation>
    <PMID>22712550</PMID>
  </reference>
  <reference>
    <citation>Dale DC, Price TH. Granulocyte transfusion therapy: a new era? Curr Opin Hematol. 2009 Jan;16(1):1-2. doi: 10.1097/MOH.0b013e32831d7953.</citation>
    <PMID>19057197</PMID>
  </reference>
  <reference>
    <citation>Lee JJ, Chung IJ, Park MR, Kook H, Hwang TJ, Ryang DW, Kim HJ. Clinical efficacy of granulocyte transfusion therapy in patients with neutropenia-related infections. Leukemia. 2001 Feb;15(2):203-7.</citation>
    <PMID>11236935</PMID>
  </reference>
  <reference>
    <citation>Ofran Y, Avivi I, Oliven A, Oren I, Zuckerman T, Bonstein L, Rowe JM, Dann EJ. Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions. Vox Sang. 2007 Nov;93(4):363-9.</citation>
    <PMID>18070282</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2015</study_first_submitted>
  <study_first_submitted_qc>September 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2015</study_first_posted>
  <last_update_submitted>September 5, 2015</last_update_submitted>
  <last_update_submitted_qc>September 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne</investigator_affiliation>
    <investigator_full_name>LIVIO PAGANO</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>granulocyte transfusions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Neutropenia</mesh_term>
    <mesh_term>Bacterial Infections</mesh_term>
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Febrile Neutropenia</mesh_term>
    <mesh_term>Hematologic Neoplasms</mesh_term>
    <mesh_term>Fever of Unknown Origin</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

